Hadassah claims Israel to run Phase III corona vaccine trial in Brazil
Only around 20 to 30 people volunteer each day to take part in the Phase II trial.
Photo of Prof. Zeev Rotstein, head of Hadassah-University Medical Center, being screened for eligibility to be vaccinated on Monday as part of the Phase II trial of the Israeli vaccine candidate Brilife. December 20, 2020(photo credit: HADASSAH)ByMAAYAN JAFFE-HOFFMAN
